Maintenance Therapy: Once the deficiency is fixed, smaller doses are needed
For understanding the mechanism and how it relates to dosing, see mechanism of action
Retatrutide Dosage in Clinical Trials The primary source of dosage data for retatrutide comes from the Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023)
In pre-clinical research, it is primarily studied for its effects on gastrointestinal healing, tendon and ligament repair, vascular growth (angiogenesis), and potential neuroprotective properties
It allows you to address the underlying cause of tissue damage and inflammation rather than just the symptoms
Known for its popularity in advanced beauty and wellness-inspired cosmetic systems